(lp0
S"Array Biopharma's 12% Drop, Explained Benzinga - Mar 20, 2017 Shares of Array Biopharma Inc , a biopharmaceutical company that focuses on drugs to treat patients suffering from cancer, lost more than 12 percent early Monday morning after announcing a disappointing update to one of its therapies.Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down - Yahoo FinanceArray Biopharma Withdraws Binimetinib NDA  - Investopedia"
p1
aS"Array Biopharma Recoups Some Of Its Losses From Sharply Lower Open Benzinga - Mar 20, 2017 Array Biopharma Inc  shares are trading lower by $0.66  at $9.90 in Monday's session. Before the open, the company announced its new drug application for its Binimetinib Monotherapy for the treatment of a rare skin cancer has&nbsp;...Short interest Of Array BioPharma Inc.  At 15753907 - Markets DailyArray BioPharma Inc.  withdrawn from US Food and drug ... - Benchmark Monitor"
p2
aS"Array BioPharma And Columbus's Egg Seeking Alpha - Mar 15, 2017 Even if we live in the age of immunotherapy and it seems that everything else is old and outdated, a company like Array , which develops small molecule for targeted therapies, has been able to grow up and become a commercial-stage&nbsp;..."
p3
aS'ARRY will file an NDA for its BRAF-MEK combo by mid-2017. Seeking Alpha - Mar 20, 2017 Array BioPharma  will file another NDA for binimetinib plus encorafenib for BRAF-positive melanoma sometime before June, 2017.'
p4
aS'Investor Review: Focusing in on Shares of Array Biopharma Inc  Baxter Review - 10 hours ago Active traders have a wide variety of technical indicators at their disposal for completing technical stock analysis. Presently, the 14-day ATR for Array Biopharma Inc  is spotted at 0.63. First developed by J. Welles Wilder, the ATR may assist ...'
p5
aS'Analytical Guide for Array BioPharma Inc. , Sprouts Farmers Market, Inc ... The USA Commerce - Mar 21, 2017 Presently Array BioPharma Inc.  stock have an ABR of 1.44. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.BRIEF-Array Biopharma provides NEMO update - Reuters'
p6
aS'Array Biopharma Inc  Expects To File NDA For COLUMBUS / BRAF ... Journal Transcript - Feb 27, 2017 Array Biopharma Inc  a biopharma firm company focused on the development, commercialization and discovery of targeted small molecule cancer treatments, released financial report for its 2Q2017 and offered an update on the&nbsp;...Stock Returns: Array BioPharma Inc  is Beating Natera Inc (NASDAQ ... - CML NewsFMR LLC is the biggest holder of Array BioPharma Inc.  - Post Analyst'
p7
aS"Analysts mean rating score stands at 1.90 while Array BioPharma Inc.'s (ARRY ... Hot Stocks Point - 15 hours ago Array BioPharma Inc.  stock price ended its day with loss -9.33% and finalized at the price of $9.13. During its last trading session, Stock traded with the total exchanged volume of 6.53 million shares."
p8
aS"Pre-Market Most Active for Mar 20, 2017 : LYG, ARRY, ESPR, GNMX, HMC, NKTR, DB ... Nasdaq - Mar 20, 2017 Lloyds Banking Group Plc  is -0.01 at $3.48, with 2,017,450 shares traded. LYG's current last sale is 152.63% of the target price of $2.28."
p9
aS'Market Check: Narrowing in on Shares of Array BioPharma Inc.  Baldwin Journal - 17 hours ago Many investors may have to work through multiple trading strategies to find one that works for them. Some individuals may be looking to monitor stock price momentum by looking at different historical data.'
p10
a.